60 Degrees Pharmaceuticals SXTP Q2 2026 earnings

FAQ

When did 60 Degrees Pharmaceuticals report Q2 2026 earnings?

60 Degrees Pharmaceuticals (SXTP) reported Q2 2026 earnings on August 14, 2026 before market open.

What were 60 Degrees Pharmaceuticals's Q2 2026 revenue and EPS?

60 Degrees Pharmaceuticals reported revenue of $210.0K and eps of $-0.90 for Q2 2026.

Did 60 Degrees Pharmaceuticals beat estimates in Q2 2026?

Revenue beat the consensus estimate of $185.0K by $25.0K. EPS missed the consensus estimate of $-0.74 by $0.16.

How did 60 Degrees Pharmaceuticals's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 108.1% from $100.9K a year earlier and eps grew 28.0% from $-1.25.

Where can I find 60 Degrees Pharmaceuticals's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001554855-26-001860) directly on SEC EDGAR. The filing index links above go to sec.gov.